PainChek Limited (ASX: PCK) aspires to lead the market in the innovative pain assessment products and offer services to help improve the quality of life, for people suffering from pain. The company’s pain assessment device PainChek® has received regulatory clearance from both Australia and Europe. The company is domiciled in Sydney and its CEO and MD is Mr Philip Daffas.